(+)-4-Cholesten-3-one>95.0%(GC)5g

5-[(methylthio)methyl]-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

4-tert-Butylphthalic anhydride, 95.0%, 1g

1-(2-Furylmethyl)-4-hydroxy-6-methylpyridin-2(1H)-one, 95.0%, 1g

tert-Butyl ((3R,5S)-5-methylpiperidin-3-yl)carbamate, 98%, 10g

5-(Chloromethyl)oxazole, 95.0%, 250mg

6-AMINO-4-METHYLPYRIDIN-3-OL, 95%, 1g

3-aminobenzoic acid, >=98%, for synthesis, 50 g, plastic packaging.

Ethyl 4,4,4-trifluorobutyrate, 96.0%, 5g

2,6-Dimethyl-4-nitroanisole, 96.0%, 5g

tert-Butyl 3,3-dimethylpiperazine-1-carboxylate, 95.0%, 5g

Pyren-1-amine, 95.0%, 1g

2-(1H-Indol-3-yl)acetaldehyde, 95.0%, 1g